Nevro Corp.

NYSE NVRO

Nevro Corp. Price to Book Ratio (P/B) on January 14, 2025: 0.50

Nevro Corp. Price to Book Ratio (P/B) is 0.50 on January 14, 2025, a -78.29% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Nevro Corp. 52-week high Price to Book Ratio (P/B) is 2.37 on January 22, 2024, which is 378.38% above the current Price to Book Ratio (P/B).
  • Nevro Corp. 52-week low Price to Book Ratio (P/B) is 0.44 on January 10, 2025, which is -11.08% below the current Price to Book Ratio (P/B).
  • Nevro Corp. average Price to Book Ratio (P/B) for the last 52 weeks is 1.16.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
NYSE: NVRO

Nevro Corp.

CEO Mr. Kevin R. Thornal
IPO Date Nov. 6, 2014
Location United States
Headquarters 1800 Bridge Parkway
Employees 1,215
Sector Health Care
Industries
Description

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

Similar companies

FNA

Paragon 28, Inc.

USD 10.28

-4.28%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

GKOS

Glaukos Corporation

USD 147.95

-2.58%

NPCE

NeuroPace, Inc.

USD 11.84

-2.23%

SGHT

Sight Sciences, Inc.

USD 3.15

-2.78%

SRDX

Surmodics, Inc.

USD 35.55

-0.81%

CVRX

CVRx, Inc.

USD 16.15

7.38%

CNMD

CONMED Corporation

USD 67.79

-2.46%

LIVN

LivaNova PLC

USD 47.63

0.66%

IRMD

IRadimed Corporation

USD 57.52

1.79%

ELMD

Electromed, Inc.

USD 31.05

1.90%

ITGR

Integer Holdings Corporation

USD 138.83

2.72%

KIDS

OrthoPediatrics Corp.

USD 23.55

-5.80%

RXST

RxSight, Inc.

USD 30.08

-2.08%

LUNG

Pulmonx Corporation

USD 6.84

-2.98%

StockViz Staff

January 15, 2025

Any question? Send us an email